Celcuity Inc. (NASDAQ:CELC) Short Interest Down 35.5% in April

Celcuity Inc. (NASDAQ:CELC - Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 2,000,000 shares, a decrease of 35.5% from the March 31st total of 3,100,000 shares. Approximately 6.4% of the company's shares are sold short. Based on an average trading volume of 272,400 shares, the days-to-cover ratio is currently 7.3 days.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. GAMMA Investing LLC lifted its holdings in Celcuity by 1,237.4% in the first quarter. GAMMA Investing LLC now owns 1,324 shares of the company's stock valued at $131,000 after acquiring an additional 1,225 shares during the period. Summit Investment Advisors Inc. lifted its stake in shares of Celcuity by 49.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 3,421 shares of the company's stock worth $45,000 after buying an additional 1,132 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Celcuity in the fourth quarter valued at about $50,000. Focus Financial Network Inc. purchased a new position in Celcuity in the first quarter worth approximately $108,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Celcuity during the fourth quarter worth $142,000. 63.33% of the stock is currently owned by hedge funds and other institutional investors.

Celcuity Stock Performance

CELC stock traded up $0.01 during midday trading on Monday, reaching $10.91. 38,966 shares of the company's stock traded hands, compared to its average volume of 298,039. The stock's 50-day moving average is $10.03 and its 200 day moving average is $12.01. Celcuity has a 52-week low of $7.58 and a 52-week high of $19.77. The company has a current ratio of 10.35, a quick ratio of 10.36 and a debt-to-equity ratio of 0.65. The stock has a market cap of $412.63 million, a P/E ratio of -4.20 and a beta of 0.56.

Celcuity (NASDAQ:CELC - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.72) by ($0.13). As a group, analysts anticipate that Celcuity will post -2.62 EPS for the current year.

Analyst Upgrades and Downgrades

CELC has been the subject of a number of analyst reports. HC Wainwright restated a "buy" rating and set a $27.00 price objective on shares of Celcuity in a research report on Tuesday, April 1st. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price target on shares of Celcuity in a report on Friday, April 11th. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Celcuity currently has an average rating of "Buy" and a consensus target price of $30.17.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.